688739 成大生物
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额171,018500,959677,008546,492506,376
投资活动产生之现金流量净额(314,899)(162,830)(1,402,283)2,890,316(3,065,985)
筹资活动产生之现金流量净额(343,489)(385,232)(522,691)(421,703)4,346,754
汇率变动对现金及现金等价物的影响9715482,2901,576(358)
现金及现金等价物净增加/(减少)(486,398)(46,554)(1,245,676)3,016,6811,786,788
期初现金及现金等价物余额4,498,0514,544,6055,790,2812,773,600986,812
期末现金及现金等价物余额4,011,6534,498,0514,544,6055,790,2812,773,600